Dr. Eric Sanchez -- Pharmaceutical Payment Report

This page provides a comprehensive transparency report for Dr. Eric Sanchez, a Dermatology physician based in Savannah, GA. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Eric Sanchez has received $43,700.60 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.

Physician Profile

The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.

Payment Summary

Dr. Eric Sanchez has received a total of $43,700.60 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $43,700.60 per transaction.

Payment Breakdown by Category

The following table shows how Dr. Eric Sanchez's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.

Payment CategoryAmountDescription
Speaking & Education$43,700.60Promotional speaking, CME events, and educational presentations

The largest payment category for Dr. Eric Sanchez is Speaking & Education, accounting for 100% ($43,700.60) of total pharmaceutical payments received. This suggests active involvement in pharmaceutical company advisory and educational programs.

Pharmaceutical Company Relationships

The following pharmaceutical and medical device companies have made payments to Dr. Eric Sanchez. Click on any company name to view their full physician payment profile and spending patterns.

CompanyTotal PaidTransactions
Regeneron Pharmaceuticals$43,700.601

Dr. Eric Sanchez has a financial relationship with Regeneron Pharmaceuticals, receiving $43,700.60 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.

AI Transparency Analysis

The following analysis was generated by artificial intelligence based on Dr. Eric Sanchez's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.

Eric Sanchez has received $43.7K across 1 pharmaceutical payments as a Dermatology physician in Savannah, GA. Top paying companies include Regeneron Pharmaceuticals ($43.7K). Dr. Sanchez received a single payment of $43,701 in 2024, which is his entire reported payment history. This payment was exclusively from Regeneron Pharmaceuticals and was for speaking engagement. His payment profile is highly concentrated, with 100% of his total amount coming from one company.

Patient Guidance: Questions to Ask Your Doctor

If Dr. Eric Sanchez is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:

Consumers should consider that a doctor's payments from pharmaceutical companies can influence their prescribing habits, and it's advisable to discuss treatment options and potential conflicts of interest with your physician. Always feel free to ask your doctor directly about their pharmaceutical relationships.

Peer Comparison: How Dr. Eric Sanchez Compares to Other Dermatology Physicians

For a dermatologist, a single large payment for speaking from a pharmaceutical company is not uncommon, but it represents the entirety of their disclosed industry payments.

Recent Payment Records

The following table shows the most recent pharmaceutical industry payments recorded for Dr. Eric Sanchez in the CMS Open Payments database. Click on any payment to view the full report.

CompanyAmountTypeDrug/DeviceDateConflict Level
Regeneron Pharmaceuticals$43,700.60speakingN/A2024-04-15Not Assessed

Frequently Asked Questions About Dr. Eric Sanchez's Pharma Payments

Below are common questions patients ask about physician pharmaceutical payment data.

How much pharma money has Eric Sanchez received?

Eric Sanchez has received a total of $43.7K across 1 payments from pharmaceutical companies. This data is publicly reported under the CMS Open Payments (Sunshine Act) program.

Is Eric Sanchez taking too much pharma money?

Eric Sanchez has received $43.7K in pharmaceutical payments. Whether this is "too much" depends on the physician's specialty (Dermatology), the types of payments, and how they compare to peers. The largest payment category is speaking ($43.7K). Payment does not imply wrongdoing, but patients should be aware and can ask their doctor directly.

What pharma companies pay Eric Sanchez?

The top pharmaceutical companies paying Eric Sanchez are: Regeneron Pharmaceuticals ($43.7K). These payments cover various categories including consulting, meals, speaking fees, and research grants.

What kinds of payments does Eric Sanchez receive?

Eric Sanchez's payments by type: speaking: $43.7K.

Should I switch doctors because of pharma payments?

Pharma payments alone are not typically reason to switch doctors. Many payments are routine (like meals at educational events) and do not indicate compromised care. Focus on: (1) whether your doctor explains treatment options clearly, (2) whether generic alternatives are discussed, (3) the overall pattern of payments, not individual transactions. If you have concerns, ask your doctor directly.

How do Eric Sanchez's payments compare to other Dermatology doctors?

To compare, look at the total amount ($43.7K), number of payments (1), and the types of payments received. Dermatology physicians may receive different payment amounts depending on subspecialty, geographic location, and academic affiliation. Use CMS Open Payments data to compare across the specialty.

How can I verify Eric Sanchez's payment data?

You can verify this data directly through the CMS Open Payments database at openpaymentsdata.cms.gov. Search by physician name or NPI number (1353949076). All data is reported by pharmaceutical companies and verified by CMS. DoctorPharmaData aggregates this public data for easier access.

Do pharma payments affect prescribing quality?

Research published in JAMA Internal Medicine and other peer-reviewed journals shows a statistical association between pharmaceutical payments and prescribing patterns. However, correlation does not equal causation. Many physician-industry interactions are legitimate (research, education, advisory boards). The Sunshine Act was created to promote transparency so patients can make informed decisions.

What stands out about Eric Sanchez's pharma payment profile?

The single, large payment for speaking suggests a potential advisory or educational role. Eric Sanchez has received $43.7K in total pharma payments.

How does Eric Sanchez compare to peers in Dermatology?

For a dermatologist, a single large payment for speaking from a pharmaceutical company is not uncommon, but it represents the entirety of their disclosed industry payments.

Are Eric Sanchez's pharma relationships typical for Dermatology?

The lack of multiple payments or diverse company affiliations makes it difficult to establish a broader pattern of industry interaction.

What should patients of Eric Sanchez know about these payments?

Consumers should consider that a doctor's payments from pharmaceutical companies can influence their prescribing habits, and it's advisable to discuss treatment options and potential conflicts of interest with your physician.

What patterns are visible in Eric Sanchez's payment history?

The data only reflects 2024, providing a limited snapshot of his payment history.

Understanding This Doctor Payment Report

This transparency report for Dr. Eric Sanchez is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:

About the Physician Payments Sunshine Act

The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.

Under this law, Dr. Eric Sanchez's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.

The Open Payments data for Dr. Eric Sanchez and all other physicians can be accessed at the official CMS Open Payments website.

Related Resources

Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.